Safety and efficacy of clot-dissolving therapies for submassive pulmonary embolism: A network meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and efficacy of clot-dissolving therapies for submassive pulmonary embolism: A network meta-analysis of randomized controlled trials

Published:2023-12 Issue: Volume: Page:
ISSN:1553-8389
Container-title:Cardiovascular Revascularization Medicine
language:en
Short-container-title:Cardiovascular Revascularization Medicine

Author:

Al Hennawi Hussam,Khedr Anwar,Khan Muhammad Khuzzaim,Ashraf Muhammad Talal,Sohail Affan,Mathbout Lein,Eissa Aalaa,Mathbout Mohammad,Klugherz Bruce

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference48 articles.

1. Evidence-based therapies for pharmacologic prevention and treatment of acute deep vein thrombosis and pulmonary embolism;Jacobs;Surg Clin North Am,2018

2. Global burden of thrombosis: epidemiologic aspects;Wendelboe;Circ Res,2016

3. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany;Keller;Eur Heart J,2020

4. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

5. Comparison of efficacy and safety between thrombolysis plus anticoagulation vs. anticoagulation alone for the treatment of acute submassive pulmonary embolism: a systematic review and meta-analysis;Pan;Curr Vasc Pharmacol,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Like a kid in a candy shop: Choosing the sweetest therapy for submassive pulmonary embolism;Cardiovascular Revascularization Medicine;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP